Location History:
- Chesire, CT (US) (2015)
- Cheshire, CT (US) (2015 - 2022)
Company Filing History:
Years Active: 2015-2022
Title: Yuchun Zhang - Innovator in Antibody Therapeutics
Introduction
Yuchun Zhang is a prominent inventor based in Cheshire, CT (US), known for his significant contributions to the field of antibody therapeutics. With a total of 9 patents to his name, Zhang has made remarkable strides in developing innovative solutions for various complement-associated disorders.
Latest Patents
Among his latest patents, Zhang has focused on Anti-C5A antibodies. These patents disclose antibodies or antigen-binding fragments that specifically bind to C5a, offering potential treatments for conditions such as atypical hemolytic uremic syndrome, age-related macular degeneration, rheumatoid arthritis, sepsis, severe burns, antiphospholipid syndrome, asthma, lupus nephritis, Goodpasture's syndrome, and chronic obstructive pulmonary disease.
Career Highlights
Zhang is currently affiliated with Alexion Pharmaceuticals, Inc., where he continues to advance his research and development efforts in the field of immunology. His work has been instrumental in paving the way for new therapeutic approaches that address critical health challenges.
Collaborations
Throughout his career, Zhang has collaborated with esteemed colleagues, including Russell P Rother and Douglas L Sheridan. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of groundbreaking therapies.
Conclusion
Yuchun Zhang's dedication to innovation in antibody therapeutics positions
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.